Exodus Point Capital Management, LP Mustang Bio, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.73 - $1.81 $38,068 - $94,387	-52,148 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.66 - $2.64 $1,660 - $2,640	1,000 Added 1.96%	52,148 $87,000
Q3 2021 Nov 15, 2021	BUY	$2.58 - $3.36 $38,700 - $50,400	15,000 Added 41.5%	51,148 $138,000
Q2 2021 Aug 16, 2021	BUY	$2.7 - $3.81 $9,342 - $13,182	3,460 Added 10.58%	36,148 $120,000
Q1 2021 May 17, 2021	BUY	$3.02 - $5.16 $98,717 - $168,670	32,688 New	32,688 $109,000
Q4 2020 Feb 16, 2021	SELL	$2.66 - $4.18 $29,978 - $47,108	-11,270 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.01 - $3.88 $33,922 - $43,727	11,270 New	11,270 $36,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.